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Abstract
Background: All human immunodeficiency virus (HIV-1) uses a host tRNALys,3 as the primer for
reverse transcription. The tRNALys,3 is bound to a region on the HIV-1 genome, the primer-binding
site (PBS), that is complementary to the 18 terminal nucleotides of tRNALys,3. How HIV-1 selects
the tRNA from the intracellular milieu is unresolved.
Results: HIV-1 tRNA primer selection has been investigated using viruses in which the primer-
binding site (PBS) and a sequence within U5 were altered so as to be complementary to tRNAMet,
tRNAPro or tRNAIle. Analysis of the replication of these viruses in human peripheral blood
mononuclear cells (PBMC) revealed preferences for the selection of certain tRNAs. HIV-1 with the
PBS altered to be complementary to tRNAMet, with and without the additional mutation in U5 to
be complementary to the anticodon of tRNAMet, stably maintains the PBS complementary to
tRNAMet following extended in vitro culture in PBMC. In contrast, viruses with either the PBS or
PBS and U5 mutated to be complementary to tRNAIle were unstable during in vitro replication in
PBMC and reverted to utilize tRNALys,3. Viruses with the PBS altered to be complementary to
tRNAPro replicated in PBMC but reverted to use tRNALys,3; viruses with mutations in both the U5
and PBS complementary to tRNAPro maintained this PBS, yet replicated poorly in PBMC.
Conclusion: The results of these studies demonstrate that HIV-1 has preferences for selection of
certain tRNAs for high-level replication in PBMC.
Background
Although the major steps in reverse transcription have
been known for some time, the process by which the
tRNA primer is specifically selected from the intracellular
milieu by the virus is less well understood. Even though
different retroviruses select different tRNA primers for
reverse transcription, within a group of retroviruses, the
tRNA primer selected is conserved [1,2]. For example,
murine leukemia virus (MuLV) selects tRNAPro, while
avian leukosis virus (ALV) selects tRNATrp [3,4]. Human
immunodeficiency virus type 1 (HIV-1), as do all lentivi-
ruses, selects tRNALys,3 for use as the primer for reverse
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transcription [5,6]. How and why HIV-1 exclusively
selects tRNALys,3 as the primer for reverse transcription is
not known. Pseudovirions composed of Gag and Gag-pol
are enriched for tRNALys, including tRNALys,3, that is used
for initiation of reverse transcription [2,7,8]. Additional
studies have shown that the specific incorporation of lysyl
tRNA synthetase and its interaction with Gag could also be
important for the specific capture of tRNALys,3 used for ini-
tiation of reverse transcription [9-11].
Substitution of the primer-binding site (PBS) to be com-
plementary to alternative tRNAs results in the capacity of
HIV-1 to transiently use these tRNAs for initiation of
reverse transcription [12-14], even though upon extended
culture, these viruses all reverted back to specifically uti-
lize tRNALys,3 for initiation of reverse transcription. In
some instances, mutation of a region 5' of the PBS so as to
be complementary to the anticodon of certain tRNAs, in
conjunction with mutations of the PBS, results in the virus
stably utilizing these alternative tRNAs for replication [15-
19]. Interestingly, analysis of the virion tRNAs of a virus
that stably utilized tRNAHis for replication did not show a
difference in composition compared to that of the wild
type virus that utilized tRNALys,3, indicating that tRNAs in
the HIV-1 virion did not necessarily reflect the tRNA
selected for initiation of reverse transcription [20].
The fact that HIV-1 can select different tRNAs for replica-
tion suggests the virus has access to a variety of tRNAs.
Recent studies from this laboratory demonstrated that the
tRNA selected by HIV-1 for replication have undergone
nuclear-to-cytoplasmic transport. Furthermore, the tRNAs
that are aminoacylated, indicating inclusion in transla-
tion, are most efficiently selected as primers [21]. The real-
ization that tRNA biogenesis and translation might
intersect with primer selection has prompted us to re-
examine the stability and replication of HIV-1 with a PBS
complementary to alternative tRNAs in a relevant cell type
peripheral blood mononuclear cells (PBMC). In a previ-
ous study, we found that HIV-1 in which the PBS was
altered to be complementary to tRNALys1,2 or tRNAHis
reverted to utilize tRNALys,3 upon extended culture in
PBMC [22]. Viruses could be generated which stably uti-
lized these tRNAs for replication if additional mutations
within the U5, consisting of nucleotides complementary
to the anticodon regions, were also included in the viral
genomes. Interestingly, viruses which utilize tRNALys1,2
had further adapted to utilize this tRNA, exhibiting repli-
cation characteristics similar to the wild type virus follow-
ing extended in vitro replication in human PBMC. Similar
results have been recently reported for HIV-1 in which the
PBS and a second region upstream, the primer activation
site (PAS), has been altered to be complementary to
tRNALys1,2 [23]. In this case, the virus stably utilized
tRNALys1,2 for an extended culture period. A mutation in
the RNase H domain of the reverse transcriptase was also
found, although the major determinant of the stability of
the PBS was correlated with the mutations in the PAS and
PBS.
In the current study, we have further examined the prefer-
ence of HIV-1 for certain tRNAs. A previous study from
this laboratory has shown that viruses with a PBS comple-
mentary to tRNAPro or tRNAIle were unstable following
replication in SupT1 cells, an immortalized, continuous,
human T cell line [24]. However, during the process of
reversion to a PBS complementary to tRNALys,3, we noted
several different anomalies with the PBS, including the
isolation of viruses with multiple PBS complementary to
other tRNAs and a virus in which the PBS was comple-
mentary to tRNAMet. Further characterization of this virus
revealed that it stably utilized tRNAMet as the initiation
primer following additional mutations in which the U5
was made complementary to the anticodon region of
tRNAMet [15,19]. We have now analyzed the replication
and stability of the PBS of viruses in which the PBS alone
was altered to be complementary to tRNAMet, tRNAPro or
tRNAIle, as well as viruses with both the PBS and U5 region
altered to be complementary to the 3' 18-nucleotides and
anticodon of these tRNAs. Clear differences were identi-
fied with respect to primer preference that correlated with
virus replication. The results of these studies therefore
establish that preferences for selection of certain tRNAs to
be used in reverse transcription by HIV-1 do exist and are
more evident following replication in PBMC than in con-
tinuous T cell lines.
Results
Construction and characterization of HIV-1 proviral 
genomes complementary to tRNAMet, tRNAPro and tRNAIle
In previous studies, we have described the construction of
HIV-1 proviral genomes in which the PBS was made com-
plementary to alternative tRNAs [15-19]. For these stud-
ies, the proviral genomes were based on HXB2, which
allows high-level replication in continuous T cell lines (eg.
SupT1s). For the current studies, we have transferred the
5' LTR up to the BssHII site (nucleotide 233) from these
clones into the NL4-3 proviral clone of HIV. The NL4-3
proviral clone of HIV-1, in contrast to the HXB clone, con-
tains open reading frames for all the accessory proteins
and replicates to high levels in PBMC. The U5-PBS regions
of the subsequent proviral constructs, named pNL4-3-
Met, pNL4-3-Pro and pNL4-3-Ile were sequenced prior to
analysis to confirm that the constructs were isogenic with
the wild type with the exception of the 3' 18-nucleotide
PBS region (Figure 1A).
To characterize these viruses, we first measured the pro-
duction of infectious virus and p24 antigen following
transfection into 293T cells. Since 293T cells do not
Retrovirology 2005, 2:21 http://www.retrovirology.com/content/2/1/21
Page 3 of 10
(page number not for citation purposes)
support HIV-1 replication, this analysis would provide us
with the inherent infectivities of viruses prior to undergo-
ing reverse transcription/replication in PBMC. In our pre-
vious studies, we noted that there was no substantial
difference in the production of virus (as measured by p24
antigen) as a result of altering the PBS in the HXB2 provi-
ral constructs [15-19]. For the current studies, we trans-
fected the proviral clones into 293T cells and determined
the amount of infectious units using the JC53BL assay;
virus production was then measured using a p24 antigen
capture ELISA. Infectivity was determined as the ratio of
infectious units to p24 antigen. The values are presented
relative to the infectivity of the wild type virus, with a PBS
complementary to tRNALys,3 (Figure 1B). All of the viruses
with altered PBS had infectivities lower than the wild type.
The virus NL4-3-Ile, with a PBS complementary to
tRNAIle, was consistently the most infectious of the
mutants with a level approximately 40% that of wild type,
while the other viruses were 10–20% as infectious as the
wild type virus.
Stability of PBS following replication in PBMC
We next wanted to determine the effects of alteration of
the PBS on the replication of these viruses in PBMC. Infec-
tions were initiated with 200 pg of p24 and were allowed
to proceed with re-feeding of PBMC every 14 days for peri-
ods of time exceeding 50 days of in vitro culture. The cul-
tures were sampled periodically, supernatants were
assayed for p24 antigen and cells were processed to extract
high molecular weight DNA to determine the stability of
the PBS. All of the viruses with an altered PBS showed an
initial delay in production of p24 antigen compared to the
wild type virus, consistent with the initial reduced infec-
tivity compared to wild type (Figure 2). The NL4-3-Met
virus had replication kinetics most similar to wild type
virus in that during the first 10 days of culture we observed
a rapid rise in p24 antigen, followed by a plateau at a level
similar to that for wild type. The NL4-3-Ile virus replicated
more slowly, with a gradual rise in p24 antigen before
finally reaching a level similar to wild type. Finally, the
U5-PBS sequence and infectivity levels of HIV-1 NL4-3 viral mutants at start of PBMC infectionFigure 1
U5-PBS sequence and infectivity levels of HIV-1 NL4-
3 viral mutants at start of PBMC infection. Panel A. 
HIV-1 U5 and PBS sequence shown (from 5' to 3'). Viral 
primer binding site (PBS) sequence was altered to be com-
plementary to the 3' terminal 18 nucleotides of tRNAIle, 
tRNAMet and tRNAPro. The PBS sequence is shadowed. 
Panel B. Comparison of infectivity of NL4-3 PBS mutants. 
HIV-1 NL4-3 proviral clones were transfected into 293T 
cells, incubated for 48 hours, and supernatants were meas-
ured for infectious units. For a given sample, the number of 
infectious units per microliter is equal to the number of blue 
cells in a well divided by the dilution factor for that well and 
represents the average of at least two wells. Wild type infec-
tivity levels were set at 100% and mutant virus infectivity was 
reported as a percentage of wild type. All viruses with 
altered PBS sequences showed reduced levels of infectivity as 
compared to wild type. Results presented are representative 
of three experiments.
Provirus
       
PBS
NL4-3-WT 5’...TTTTAGTCAGTGTGG AAAA TCTCTAGCAG TGGCGCCCGAACAGGGAC TTGAAAGCG… 3’
NL4-3-Ile
NL4-3-Met
NL4-3-Pro
5’...TTTTAGTCAGTGTGG AAAA TCTCTAGCAG TGGTGGCCCGTACGGGGA TTGAAAGCG… 3’
5’...TTTTAGTCAGTGTGG AAAA TCTCTAGCAG TGGTGCCCCGTGTGAGGA TTGAAAGCG… 3’
5’...TTTTAGTCAGTGTGG AAAA TCTCTAGCAG TGGGGGCTCGTCCGGGAT TTGAAAGCG… 3’
A
B
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Replication of HIV-1 with PBS sequence altered to be com-pl men ary to the 3' 18 nucleotides of tRNAIle, tRNAMet and tRNAPro in human perip eral blood mononuclear cells (PBMC)Figure 2
Replication of HIV-1 with PBS sequence altered to be 
complementary to the 3' 18 nucleotides of tRNAIle, 
tRNAMet and tRNAPro in human peripheral blood 
mononuclear cells (PBMC). Infections were initiated with 
transfection supernatant containing approximately 200 pg of 
p24 antigen in a volume of 10 mLs of media, giving a final p24 
level of 20 pg/mL on day zero. At 14 day intervals, 5 × 106 
fresh PHA stimulated PBMC were added to each culture. 
Supernatants were assayed for p24 viral antigen using an 
ELISA. Two additional separate infections produced similar 
replication patterns for each virus. Squares are wild type 
NL4-3; diamonds are NL4-3-Met; open circles are NL4-3-Ile 
and closed circles are NL4-3-Pro.
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NL4-3-Pro virus showed minimal replication in the first
21 days of culture, followed by a rapid increase in the next
14 days to reach levels similar to that of the wild type virus
(Figure 2). Although all of the viruses replicated in PBMC,
the kinetics did not correlate with the initial infectivities
from the 293T transfection supernatants.
During the culture period, we collected the DNA from the
cells to determine the status of the integrated virus PBS.
The wild type virus, as expected, maintained a PBS com-
plementary to tRNALys,3 throughout the entire culture
period (data not shown). In contrast, viruses with a PBS
complementary to tRNAIle initially used tRNAIle for reverse
transcription, but by day 21 from the initiation of culture
had reverted to be complementary to tRNALys,3 (Table 1).
Viruses in which the PBS was altered to be complementary
to tRNAPro (NL4-3-Pro) appeared to be slightly more sta-
ble and maintained the PBS complementary to this tRNA
through day 21 of culture, before reverting to wild type by
day 35. However, the subsequent rapid replication of the
virus corresponded with the presence of a PBS comple-
mentary to tRNALys,3 (Table 1).
Surprisingly, the viruses in which the PBS was comple-
mentary to tRNAMet remained stable for use of tRNAMet
throughout the complete culture period (in this case, up
to 63 days post initiation of culture). Analysis of 34 indi-
vidual TA clones of the PBS from these viruses revealed
that all were complementary to tRNAMet (Table 1). This is
the first instance in which we have found a virus that sta-
bly maintains a PBS complementary to an alternative
tRNA (not tRNALys,3) following extensive in vitro replica-
tion that did not have additional mutations in U5. Previ-
ously, analysis of this virus in the HXB2 proviral clone
revealed that the PBS was unstable following replication
of the virus in vitro in SupT1 cells and reverted back to use
tRNALys,3 [15,18]. We further characterized the replication
of this virus compared to wild type virus at different times
during the culture period. Analysis of p24 antigen produc-
tion from this virus at day 56 post initiation of culture
revealed that it replicated similar to the wild type virus,
albeit with slightly lower levels of p24 antigen (data not
shown). The infectivity of the virus obtained after long-
term culture, which utilized tRNAMet, was approximately
50–80% of the wild type virus (data not shown). Collec-
tively, the results of these studies establish that HIV-1 has
a preference for certain tRNAs, such as tRNAMet, for the
selection as primer for reverse transcription.
Effect of mutations in U5 on replication of viruses that use 
alternative tRNAs
In previous studies, we have found that with a PBS com-
plementary to tRNALys1,2, tRNAMet, tRNAGlu and tRNAHis,
the additional mutation in which the U5 region was made
complementary to the anticodon stabilized the HXB2 pro-
viral clones to allow continuous use of the alternative
Table 1: Stability of PBS following extended culture in PBMC
Virus PBS Sequence Time to Reversion1(days)
NL4-3-lle Lys,32 21
NL4-3-Met Met3 ---4
>NL4-3-Pro Lys,3 35
1. PBS analyzed at the time of in vitro culture in PBMC and found to be 
wild type, complementary to tRNALys,3.
2. PBS complementary to tRNALys,3.
3. PBS complementary to tRNAMet.
4. Analysis of 34 TA clones of the PBS following 63 days in culture 
revealed all maintained a PBS complementary to tRNAMet.
U5-PBS sequence and Infectivity levels of HIV-1 NL4-3 viral mutants with alt red U5 and PBS sequences at start of PBMC infectionFigure 3
U5-PBS sequence and Infectivity levels of HIV-1 NL4-
3 viral mutants with altered U5 and PBS sequences 
at start of PBMC infection. Panel A. HIV-1 U5 and PBS 
sequence (shown 5' to 3'). Viral primer binding site (PBS) and 
U5 A-loop sequences were altered to be complementary to 
the 3' terminal 18 nucleotides and anticodon loop of tRNAIle, 
tRNAMet, tRNAPro, and tRNATrp, respectively. U5 A-loop 
sequence and PBS are shadowed. Panel B. Comparison of 
the infectivity of U5-PBS mutant NL4-3 viruses. HIV-1 NL4-3 
proviral clones were transfected into 293T cells, incubated 
for 48 hours, and supernatants were measured for infectious 
units. For a given sample, the number of infectious units per 
microliter is equal to the number of blue cells in a well 
divided by the dilution factor for that well and represents the 
average of at least two wells. Wild type infectivity levels were 
set at 100%, and mutant virus infectivity was reported as a 
percentage of wild type. All viruses with altered U5 and PBS 
sequences had reduced levels of infectivity as compared to 
wild type virus. The data presented are representative for 
three independent experiments.
Provirus
                    
A-loop
                             
PBS
NL4-3-WT 5’...TTTTAGTCAGTGT GGAAAAT  CTCTAGCAG TGGCGCCCGAACAGGGAC TTGAAAGCG…3’
NL4-3-Met-AC
NL4-3-Pro-AC
5’...TTTTAGTCAGTGG CTTATCAT CTCAGCCAG TGGTGGCCCGTACGGGGA TTGAAAGCG…3’
5’...TTTTAGTCAGTGT TGTGAGA  CTCTAGCAG TGGTGCCCCGTGTGAGGA --GAAAGCG…3’
5’...TTTTAGTCAGTGT ACCCCAAG CTCTAGCAG TGGGGGCTCGTCCGGGAT TTGAAAGCG…3’
A
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tRNA during replication [16,19,24,25]. In contrast, in the
HXB2 provirus, modification of the U5 region for viruses
in which the PBS was made complementary to tRNAPro or
tRNAIle did not result in virus that could stably utilize
these tRNAs following replication [24]. To determine if
this would be case for viruses that were grown in PBMC,
we constructed HIV-1 in which both the U5 and PBS were
made complementary to tRNAMet, tRNAPro or tRNAIle (Fig-
ure 3A). The initial infectivities of the viruses were ana-
lyzed following transfection of the proviral clones into
293T cells. Similar to what we observed for viruses with
just the PBS altered to be complementary to these tRNAs,
the viruses with both the U5 and PBS altered demon-
strated infectivities lower than wild type virus. In this case,
the levels ranged from a low of 5% (NL4-3-Pro-AC) to a
high of 30% (NL4-3-Met-AC) (Figure 3B). We initiated
infections in PBMC with the same amount of p24 antigen.
We noted a delay in the production of p24 antigen in the
cultures of viruses in which both the PBS and A loop were
mutated to be complementary to the alternative tRNAMet
or tRNAIle, relative to the wild type virus (Figure 4). By day
21, the viruses derived from pNL4-3-Met-AC had p24
antigen levels in the culture supernatants similar to that
for the wild type virus. Viruses derived from pNL4-3-Ile-
AC replicated at levels approximately 1/10 that of the wild
type virus, while viruses derived from pNL4-3-Pro-AC did
not replicate well (or at all), as evidenced by p24 levels
that did not increase substantially over the culture period
(Figure 4).
We next analyzed the PBS of the viruses. Consistent with
our previous studies, we found that the viruses in which
both the U5 and PBS were complementary to tRNAMet
remained stable during the culture period (Table 2).
Sequence analysis of the virus that stably utilized tRNAMet
(NL4-3-Met-AC) revealed a few nucleotide changes
outside of the PBS. Previous studies from our laboratory
have reported single nucleotide changes, noting that these
changes might be important in stabilizing RNA structures
to facilitate more effective primer selection [15,17-20,24].
Further experiments will be needed to address this issue.
Characterization of NL4-3-Met-AC after extended culture
revealed that it had infectivities that were still lower than
that of the wild type virus (data not shown). In fact, the
infectivities of the virus derived from pNL4-3-Met-AC
were generally lower than those from the virus derived
from pNL4-3-Met (data not shown). In contrast, viruses in
which the PBS and U5 region were made complementary
to tRNAIle were not stable and reverted to utilize tRNALys,3
following in vitro replication (Table 2). Thus, the A loop
modification did not stabilize the virus to continuously
use tRNAIle for replication in PBMC. Virus with both the
U5 and PBS altered to be complementary to tRNAPro rep-
licated poorly in the in vitro culture. Amplification of the
region containing the PBS required use of a double PCR
method in which the initial PCR product was used as the
template of the second reaction (double PCR). Sequence
analysis revealed that NL4-3-Pro-AC had maintained a
PBS complementary to tRNAPro (data not shown). Viruses
in which the U5 and PBS were made complementary to
tRNAPro also reverted to use wild type following replica-
tion in SupT1 cells; in this case, we found viruses which
contained multiple PBS, some of which were complemen-
tary to tRNALys,3. Following replication in PBMC, though,
we did not isolate viruses with multiple PBS and all the
viruses isolated contained a PBS complementary to tRN-
APro. Collectively, the results of these studies establish that
HIV-1 does have a preference for tRNAMet over tRNAPro
with respect to the selection of the tRNA primer for repli-
cation. Furthermore, tRNAIle is not favored for selection by
HIV-1 even if compensatory mutations are provided in
which the U5 region has been made complementary to
the anticodon region.
Discussion
In previous studies, we have described HIV-1 in which the
PBS and U5 have been altered to be complementary to
Replication of HIV-1 with U5 and PBS sequence altered to be complementary to the anticodon loop and 3' 18 nucleo ides of tRNAIle, RNAMet, tRNAPro and tRNATrp i  PBMCFigur  4
Replication of HIV-1 with U5 and PBS sequence 
altered to be complementary to the anticodon loop 
and 3' 18 nucleotides of tRNAIle, tRNAMet, tRNAPro 
and tRNATrp in PBMC. Infections were initiated with 
transfection supernatant containing approximately 200 pg of 
p24 antigen in a volume of 10 mLs of media, giving a final p24 
level of 20 pg/mL on day zero. Supernatants were assayed for 
p24 viral antigen every 7 days for a period of 42 days. At 14-
day intervals, 5 × 106 fresh PHA stimulated PBMC were 
added to each culture. Two additional separate infections 
produced very similar replication patterns for each virus 
(data not shown). Squares are NL4-3 wild type; diamonds are 
NL4-3-Met-AC; open circles are NL4-3-Ile-AC; closed cir-
cles are NL4-3-Pro-AC.
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tRNAMet, tRNAPro and tRNAIle [18,24]. All of the viruses
with only a PBS complementary to these tRNAs were
replication competent but reverted to the wild type fol-
lowing infection in SupT1. To extend these studies to a
more relevant cell type, we cloned the mutant PBS into the
NL4-3 background, which replicates well in PBMC,
reaching high levels of p24 antigen in the culture superna-
tant. Analysis of the effect of altering the PBS on infectivity
of proviral clones revealed that these viruses were 10–40%
as infectious as the wild type virus, with the virus contain-
ing a PBS complementary to tRNAIle being the most infec-
tious. However, analysis of the growth of these viruses
revealed a clear preference for the viruses with a PBS
complementary to tRNAMet compared to the virus with a
PBS complementary to tRNAIle. Virus with a PBS comple-
mentary to tRNAPro had a rapid increase in p24 antigen
after 21 days in culture and subsequently replicated simi-
lar to wild type and viruses with a PBS complementary to
tRNAMet. As we had found in our previous studies, the
sequence analysis of the PBS from both of these viruses at
different times of culture revealed the reversion of the PBS
to wild type [24]. The unexpected result from our studies
was the distinct preference for HIV-1 to utilize tRNAMet as
evidenced by the stability of the PBS following long-term
culture. The preference of HIV-1 for the selection of
tRNAMet was noted in a previous study in which we found
a PBS complementary to this tRNA following analysis of
the reversion of viruses that initially had a PBS comple-
mentary to tRNATrp [24]. A subsequent study found that
HXB2 derived viruses in which only the PBS was mutated
to be complementary to tRNAMet reverted back to the wild
type PBS; a virus that could stably use tRNAMet was
obtained by additional mutations in the U5 [15]. Thus,
the results of our current study are unique in that the NL4-
3-Met, without mutations in the U5, was stable and repli-
cated well in PBMC, at a level comparable to the wild type
virus. Further characterization of the viruses obtained
from these two cell types will be needed to resolve the rea-
Table 2: Analysis of U5-PBS from viruses following extended in vitro culture in PBMC
Virus U5-PBS Days Post-
Culture
Ile3
NL4-3-Ile-AC 15' AGTCAGTGTTTATCAGCTCTAGCAG 2TGGTGGCCCGTACGGGGA TTGAAA 3' Input5 0
Ile
45' ************************* ****************** ****** 3' PCR Product6 21
Lys, 3
5' ************************* TGGCGCCCGAACAGGGAC -***** 3' 6/7 TA Clones7 35
Lys,1,2
5' ************************* TGGCGCCCAACGTGGGGC -***** 3' 1/7 TA Clones 35
Lys, 3
5' ************************* TGGCGCCCGAACAGGGAC -***** 3' PCR Product 73
Met
NL4-3-Met-
AC 5
5' AGTCAGTGTTGTGAGACTGTAGCAG TGGTGCCCCGTGTGAGGC GAAAGC 3' Input 0
Met
5' ************************* ****************** ****** 3' 5/10 TA 
Clones
35
5' ************************* *****************A ****** 3' 3/10 TA 
Clones
35
5' ********************* *A* * ****************** ****** 3' 1/10 TA 
Clones
35
5' ************************* *******T********** ****** 3' 1/10 TA 
Clones
35
Met
5' ************************* ****************** A***** 3' 6/9 TA Clones 63
5' ************************* *****************A A***** 3' 2/9 TA CIones 63
5' *********C*****G********* ****************** A***** 3' 1/9 TA CIones 63
1. The U5-loop is in bold type.
2. Spaces separate the PBS (indicated in bold type) from flanking sequence.
3. PBS complementary to the 3' terminal 18-nucleotide sequence of the indicated host tRNA.
4. Asterisks represent conserved nucleotides.
5. "Input" refers to the clone that was used to initiate viral infection in PBMCs.
6. PCR product that was sequenced directly.
7. Refers to TA clones of PCR product that is cloned into the Promega, P-Gem T-Easy Vector System I, to isolate individual colonies for sequencing.
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son for differences in stability of the PBS. It is possible that
differences in nucleotide concentrations or tRNA availa-
bility between the SupT1 or PBMC could influence the sta-
bility of the PBS. Further experiments using an
endogenous RT reaction [18] and analysis of virus
tRNAMet content could be informative. With respect to the
latter point though, our previous studies have not shown
differences in tRNA content of virions that use alternative
primers for reverse transcription [20].
How does this relate to the process of primer selection? In
recent studies, we have found that HIV-1 most effectively
selects tRNAs that have undergone the steps in tRNA bio-
genesis that result in transport from the nucleus to the
cytoplasm [21]. Once in the cytoplasm, the tRNAs interact
with a myriad of proteins involved in translation [26]. At
any one time, the tRNA selected by HIV-1 as a primer for
reverse transcription has been channeled into the transla-
tional process, supporting the idea of coupling of transla-
tion and primer selection. One possibility could be the
coupling of primer selection with the synthesis of the Gag-
pol polyprotein. Previous studies have shown that
pseudovirions composed of Gag and Gag-pol contain the
appropriate ratios of tRNALys found in intact wild type vir-
ions [7,8]. That is, during the translation of Gag-pol, the
tRNAs available for selection might be enriched for tRNA-
Lys,3 and tRNAMet; conversely, tRNAIle may not be favored
because of the absence of isoleucine during translation of
Gag-pol. This is not because isoleucine is excluded from
the Gag-pol protein. Rather, it is possible that a transla-
tional event in the production of Gag-pol, possibly at or
during the frame shifting, could influence the local
amounts of tRNA so as to favor some (e.g., tRNALys,3,
tRNAMet) while not others (e.g., tRNAIle). Without tRNAIle
to occupy the PBS, there would be greater access by tRNA-
Lys,3 to facilitate reversion back to the wild type PBS, com-
plementary to tRNALys,3. Viruses with a PBS
complementary to tRNAPro, and from previous studies
those with PBS complementary to tRNAHis, tRNALys1,2 or
tRNAGlu, initially replicated slowly but reverted to use
tRNALys,3, whereupon they exhibited rapid replication. We
would predict that the local availability of these tRNAs
would be sufficient to allow the limited replication. How-
ever, given the selective pressure for the use of tRNALys,3,
the virus would have a propensity to revert to wild type if
the tRNAs were not present at levels similar to tRNALys,3 or
tRNAMet. Coupling of the synthesis of Gag-pol with primer
tRNA selection and encapsidation might provide all of the
necessary components for the generation of infectious
virus within the same intracellular locale. Further studies
will be needed to explore the relationship between the
synthesis of Gag-pol and primer selection using the unique
viruses described in this study.
The results of our studies in which we included additional
regions of complementarity between the tRNA and U5
further substantiates a role for this interaction in the selec-
tion of the tRNA primer [24]. In a recent study, we found
that viruses with PBS and U5 complementary to tRNALys1,2
or tRNAHis were stable after extended replication in PBMC,
similar to what we found for NL4-3-Met-AC [22]. In this
study, the virus derived from NL4-3-Pro-AC replicated
poorly and in contrast to NL4-3-Pro, did not revert to wild
type following extensive in vitro culture in PBMC. This
finding supports the idea that the complementarity
between the U5 and tRNA can impact the selection proc-
ess. Most probably, the NL4-3-Pro-AC remains stable
because it can more effectively select tRNAPro, or exclude
tRNALys,3, from binding to the PBS complementary to
tRNAPro. If tRNALys,3 is used, the PBS generated during plus
strand synthesis would be complementary to tRNALys,3,
which could facilitate reversion upon subsequent replica-
tion. The results of the current study and others are con-
sistent with the concept that multiple interactions
between the viral RNA genome and tRNA occur during the
selection process [16,19,23,24]. A recent study found that
a virus that stably used tRNALys1,2 could be generated by
changing the PBS and a region upstream, different from
the A loop, designated as the primer activation site (PAS)
[23]. Interestingly, a virus with similar mutations to facil-
itate the use of tRNAPro was not stable, consistent with the
results presented in our study. We suspect that the U5-PBS
interactions are more important for tRNA selection in pri-
mary cells (e.g., PBMC) where the availability of the
tRNAs in the intracellular environment might be different.
Further experiments will be needed to address this issue.
In summary, the results of our studies analyzing the repli-
cation in PBMC of HIV-1 with PBS complementary to
alternative tRNAs has revealed a clear preference for cer-
tain tRNAs to be selected for replication. The tRNAMet is
highly favored for selection, slightly less than the wild
type tRNALys,3, while tRNAIle is not favored for selection as
evidenced by the fact that viruses with this U5-PBS revert
to use tRNALys,3 after short term culture. Viruses that use
tRNAs such as tRNAPro, tRNALys1,2 or tRNAHis replicate
poorly in PBMC compared to the wild type virus and the
virus that uses tRNAMet [22]. These results suggest that
HIV-1 can select the tRNA primer from a pool of tRNAs,
with certain tRNAs favored over others, further substanti-
ating a link between viral protein translation and primer
selection.
Conclusion
The results of our study provide new insights into the
tRNA selection process by HIV-1. For the first time, we
have described a unique HIV-1 that utilizes a tRNA primer
(tRNAMet) that does not require additional mutations
within the U5. This virus replicates well in human PBMC,
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similar to the wild type virus. In contrast, the virus did not
prefer to select tRNAIle as evidenced by the fact that this
virus was unstable with or without additional mutations
within U5. This result highlights that different tRNAs are
available in PBMC for capture by HIV-1 for use as the
primer for reverse transcription. The importance of addi-
tional mutations within U5 that are complementary to the
anti-codon region of tRNAs for selection was highlighted
by the studies with viruses in which the PBS was made
complementary to tRNAPro. In this case, the virus was
unstable with only the PBS complementary to tRNAPro
while the additional U5 mutation did not allow reversion
but severely impacted on the subsequent replication
capacity of the virus, demonstrating that complex RNA-
RNA interactions occur within the U5-PBS during primer
selection. Collectively, the results of our studies demon-
strate, for the first time, that distinct preferences exist for
the selection of tRNAs to be used as the primer for HIV-1
reverse transcription. Coupled with our previous studies,
we conclude there is most probably a link between viral
translation and primer selection. The exclusive use of tRN-
ALys,3 by HIV-1 is most probably due to inherent features
of this tRNA as well as the intracellular availability during
viral translation.
Methods
Construction of NL4-3 proviruses containing modified PBS 
regions
We previously reported the construction of pHXB2 (Met
and Met-AC) and pHXB2 (Ile and Ile-AC) and PHXB2
(Pro and Pro-AC) with PBS and PBS-U5 changes compli-
mentary to the respective tRNA 3' and anticodon
sequences [15,18,19,24]. These proviral mutants were
constructed in the pHXB2 molecular clone of HIV-1. In
this study, the NL4-3 molecular clone of HIV-1 was used
as the proviral backbone DNA for the U5-PBS mutants
[27]. Proviral clones pHXB2 (Met, Met-AC, Pro, Pro-AC,
Ile and Ile-AC) from these previous studies were digested
with HpaI and BssHII restriction enzymes (New England
Biolabs, Beverly, MA) to release an 868-bp fragment that
contained the 5' LTR, PBS, and leader region from the gag
gene of HXB2. The HpaI site is located upstream of the 5'
LTR within the flanking sequence, and the BssHII site is
located downstream of the PBS within the viral genome,
in the proximity of nucleotide 255 (5'GCGCGC-3').
Digests were run on a 1% Agarose gel (Amresco, Solon,
OH) to separate the 868 bp U5-PBS fragment from the
pHXB2 proviral DNA fragment. U5-PBS fragments were
isolated using the Qiagen Gel Extraction kit (Qiagen,
Valencia, CA) and cloned into the NL4-3 HIV-1 proviral
plasmid using the same BssHII and HpaI restriction sites.
All resulting NL4-3 constructs were verified by DNA
sequencing to ensure the identity of the mutated sequence
and the successful ligation of the U5-PBS fragment into
the pNL4-3.
Tissue Culture and DNA transfections
Transfections were performed according to the protocol
for the Fugene 6 Transfection Reagent (Roche Molecular
Biochemicals, Indianapolis, IN). Briefly, 2 µg of proviral
plasmid DNA and 3 µL Fugene reagent were added to 100
µL of Dulbecco's modified Eagle's Medium (no Fetal
Bovine Serum) (Cellgro by Mediatech, Herndon, VA).
This mixture was incubated at room temperature for
approximately 45 minutes then added drop-wise to one
well of a 6-well plate containing 60% confluent 293T cells
in DMEM with 10% Fetal Bovine Serum (FBS). The trans-
fections were incubated overnight at 37°C and the
medium was replaced with fresh DMEM containing 10%
FBS (Hyclone, Logan, UT). After 48-hours, all superna-
tants were collected and stored at -80°C. Supernatants
from transfected cells were assayed for HIV-1 p24 antigen
(Beckman Coulter, Miami, FL) and infectivity [28].
PBMC Infections
Human peripheral blood mononuclear cells (PBMC)
were collected, stimulated using rIL-2 phytohemaggluti-
nin (PHA) (Sigma, St. Louis, MO) and maintained as
described previously [22]. Infections were performed by
innoculating 20 × 106 PHA-stimulated PBMC with a
volume of transfection supernatant containing 200 pg of
p24 antigen and incubating for 2 hours at 37°C and 5%
CO2. Virus/PBMC mixtures were transferred to 25 cm2 tis-
sue culture flasks, and the final volumes were adjusted to
10 mL with RPMI 1640, 1× (Cellgro by Mediatech,
Herndon, VA) containing 15% FBS (Hyclone, Logan, UT)
and 30 U/mL rIL-2 (Sigma, St. Louis, MO).
Infected PBMC cultures were maintained for 10 weeks by
replacing half the volume of medium every 7 days, with-
out removing PBMC. Every 7 days, 1 mL of cell suspen-
sion was removed and centrifuged in an Eppendorf
microcentrifuge at 24,000 × g for 2 minutes. Supernatant
was separated from the cell pellet and stored at -80°C for
further analysis by p24 ELISA and JC53BL infectivity
assays. Cell pellets were also stored at -80°C for isolation
of high molecular weight DNA. Every 14 days an
additional 5 × 106 PHA-stimulated PBMC were added to
each culture.
Infectivity Assay
Levels of infectious virus (IU/µL) in both 293T and PBMC
culture supernatants were determined using the JC53BL
assay as previously described [22,28]. For a given test
sample, the number of infectious units per microliter is
equal to the number of blue cells in a well divided by the
dilution factor for that well and represents the average of
at least two wells.
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PCR analysis of integrated PBS-containing proviral DNA
Cell pellets from virus cultures were stored at -80°C, and
isolation of high molecular weight genomic DNA was per-
formed as described previously [22]. Approximately 2 µg
of each genomic DNA sample was PCR amplified using 5
pmole/µL EcoRI (5'-CGGAATTCTCTCCTTCTAGCCTC-
CGCTAGTC-3') and 5 pmole/µL SphI (5'-CCTTGAGCAT-
GCGATCTACCACACACAAGGC-3') primers (Gibco BRL,
Rockville, MD) with 2.5 mM dNTP, 50 mM MgC12 (Invit-
rogen, Grand Island, NY), and 5 U/µL Recombinant TAQ
DNA polymerase (Invitrogen, Grand Island, NY). The
PCR program used to amplify genomic DNA had a dena-
turation temperature of 94°C and an annealing tempera-
ture of 56°C. The resulting PCR product was isolated and
purified as described previously [22]. In cases of low virus
replication (eg. pNL4-3-Pro-AC), the PCR product was
used as a template for an additional PCR reaction
(referred to as double PCR).
Subcloning of PCR products and DNA Sequencing
Purified PCR product was sequenced for the U5-PBS
region of the viral genome using the EcoRI primer (Invit-
rogen, Grand Island, NY). DNA sequencing was per-
formed on an automated DNA sequencer. PCR products
that resulted in accordant sequence throughout the U5-
PBS region were considered to be a homogenous infection
of virus, using the same tRNA primer. PCR products that
resulted in discordant sequence in the PBS region were
considered to be a heterogeneous population of virus,
using more than one tRNA to prime reverse transcription,
and was therefore, subjected to further TA cloning in order
to isolate sequences of individual viruses. This PCR prod-
uct was subcloned according to the Promega pGEM-T Easy
Vector System I (Promega, Madison, WI) to prepare the
DNA for efficient and accurate sequencing. PCR product
was ligated into the pGEM-T Easy plasmid vector at 4°C
overnight. Ligations were then transformed into DH5α
Escherichia coli cells (Invitrogen, Grand Island, NY) and
grown overnight on LB with 100 µg/mL ampicillin and 20
mg/mL Xgal. White colonies (indicating successful liga-
tion) were picked and grown in LB-Amp100 µg/mL broth
overnight at 37°C. DNA was harvested using the Qiagen
QIAprep Spin miniprep kit, according to protocol (Qia-
gen, Valencia, CA). To assure that the TA clone DNA con-
tained the PCR product insert, samples were digested by
EcoRI to release the ligated fragment. Digests were run on
a 1% agarose gel to verify the presence of a band of
approximately 750 bp size. The TA clone DNA was then
sequenced for the U5-PBS region using the EcoRI primer.
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